影响输卵管妊娠保守治疗疗效的因素分析
Analysis of Factors Affecting the Efficacy of Conservative Treatment for Tubal Pregnancy
DOI: 10.12677/acm.2024.1492532, PDF,   
作者: 张 咪, 王 柳, 张 萌, 洪文康:西安医学院研工部,陕西 西安;单 莉*:西北妇女儿童医院妇二科,陕西 西安
关键词: 输卵管妊娠甲氨蝶呤米非司酮异位妊娠Tubal Pregnancy Methotrexate Mifepristone Ectopic Pregnancy
摘要: 目的:本研究目的是探讨影响保守治疗输卵管妊娠疗效的因素。方法:收集西北妇女儿童医院2022年1月~2023年1月收治的138例符合排纳标准的输卵管妊娠妇女,且所有患者均接受甲氨蝶呤配伍米非司酮保守治疗输卵管妊娠,本研究将被保守治疗的患者分为治疗成功组和治疗失败组,进行两组之间的差异比较。结果:本研究结果表明,治疗成功组与治疗失败组在停经天数和腹痛天数以及初始β-HCG值方面存在显著统计学差异(P < 0.05)。结论:本次研究结果提示患者停经天数、腹痛天数以及初始β-HCG值可能在甲氨蝶呤配伍米非司酮保守治疗异位妊娠成功率方面扮演重要角色。
Abstract: Objective: The objective of this research was to investigate the variables that impact the effectiveness of conservative management in cases of ectopic pregnancy. Methods: 138 cases of patients with tubal pregnancy from January 2022 to January 2023 in Northwest Women’s and Children’s Hospital were treated with the conservative medical treatment with Methotrexate mifepristone; the participants were categorized into two group. A comparison was conducted to assess the disparities between these two groups. Results: The findings indicated significant statistical variations in terms of menopause duration, abdominal pain duration, and initial β-HCG value between the treatment of success of group and losing treatment group (P < 0.05). Conclusion: The results suggest that the duration of menopause, the duration of abdominal pain, and the initial β-HCG value were examined in this study may play an important role in the success of conservative treatment of ectopic pregnancy with methotrexate and mifepristone this time.
文章引用:张咪, 单莉, 王柳, 张萌, 洪文康. 影响输卵管妊娠保守治疗疗效的因素分析[J]. 临床医学进展, 2024, 14(9): 801-805. https://doi.org/10.12677/acm.2024.1492532

参考文献

[1] 王晓璐. 632例异位妊娠药物保守治疗的影响因素分析[D]: [硕士学位论文]. 太原: 山西医科大学, 2015.
[2] 姜雪峰, 徐燕. 异位妊娠保守治疗前血β-hCG的变化对选择用药方案的临床疗效分析[J]. 中国妇产科临床杂志, 2020, 21(1): 65-66.
[3] 唐薇. 药物保守治疗联合临床干预治疗异位妊娠患者的疗效分析[J]. 中国现代药物应用, 2022, 16(16): 147-149.
[4] 冯婷婷. 米非司酮联合甲氨蝶呤治疗异位妊娠的临床疗效[J]. 临床合理用药, 2023, 16(5): 137-139.
[5] 任寰. 异位妊娠药物保守治疗效果观察及预后影响因素分析[J]. 中国医药导报, 2013, 10(7): 66-67.
[6] 戴秋香, 杨舒盈, 余丽金, 等. 甲氨蝶呤对异位妊娠血清人绒毛膜促性腺激素高值患者的疗效及安全性[J]. 中国现代医学杂志, 2023, 33(3): 83-86.
[7] 曹梅. 异位妊娠药物保守治疗效果及相关因素分析[J]. 国际感染病学(电子版), 2020, 9(1): 37-38.
[8] 王晓璐, 赵烨. 301例异位妊娠药物保守治疗影响因素的临床分析[J]. 中国医药科学, 2015(8): 73-75.
[9] 王芳. 血清β-HCG及孕酮检测在79例异位妊娠保守治疗中的临床意义[J]. 中国民族民间医药, 2014(15): 88-88, 91.
[10] Lipscomb, G.H., McCord, M.L., Stovall, T.G., Huff, G., Portera, S.G. and Ling, F.W. (1999) Predictors of Success of Methotrexate Treatment in Women with Tubal Ectopic Pregnancies. New England Journal of Medicine, 341, 1974-1978. [Google Scholar] [CrossRef] [PubMed]
[11] 张洪娟, 唐莉鸿, 张爱华. 异位妊娠中手术治疗和药物保守治疗对再次妊娠的影响[J]. 当代医学, 2021, 27(20): 57-60.
[12] 陈仁武, 卜君媛. 影响异位妊娠保守治疗效果的相关因素[J]. 中国现代医生, 2012, 50(13): 11-12.
[13] Grigoriu, C., Bohiltea, R.E., Mihai, B.M., Zugravu, C.A., et al. (2022) Success Rate of Methotrexate in the Conservative Treatment of Tubal Ectopic Pregnancies. Experimental and Therapeutic Medicine, 23, 150.
[14] Bickell, N.A., Bodian, C., Anderson, R.M. and Kase, N. (2004) Time and the Risk of Ruptured Tubal Pregnancy. Obstetrics & Gynecology, 104, 789-794. [Google Scholar] [CrossRef] [PubMed]
[15] Li, P., Lin, W. and Ding, D. (2022) Risk Factors and Clinical Characteristics Associated with a Ruptured Ectopic Pregnancy. Medicine, 101, e29514. [Google Scholar] [CrossRef] [PubMed]